Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer.
Rasing MJA, Peters M, van Son M, Moerland MA, Eppinga W, van de Pol SMG, Noteboom J, Lagendijk J, van der Voort van Zyp JRN. Rasing MJA, et al. Among authors: van der voort van zyp jrn, van son m, van de pol smg. Radiother Oncol. 2023 Mar;180:109495. doi: 10.1016/j.radonc.2023.109495. Epub 2023 Jan 25. Radiother Oncol. 2023. PMID: 36708924 Free article.
Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results. In regard to Genebes et al.
Moerland MA, Maenhout M, van der Voort van Zyp JR, Noteboom JL, Eppinga WS, van Vulpen M, Monninkhof EM, Verkooijen HM. Moerland MA, et al. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):436-7. doi: 10.1016/j.ijrobp.2014.02.020. Epub 2014 May 5. Int J Radiat Oncol Biol Phys. 2014. PMID: 24837898 No abstract available.
Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation.
Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, Kerkmeijer LG, Pameijer FA, Veldhuis WB, van der Voort van Zyp JR, Pos FJ, Heijmink SW, Kalisvaart R, Teertstra HJ, Dinh CV, Ghobadi G, van der Heide UA. Steenbergen P, et al. Radiother Oncol. 2015 May;115(2):186-90. doi: 10.1016/j.radonc.2015.04.012. Epub 2015 Apr 29. Radiother Oncol. 2015. PMID: 25935742 Free article.
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Peters M, Hoekstra CJ, van der Voort van Zyp JR, Westendorp H, van de Pol SM, Moerland MA, Maenhout M, Kattevilder R, van Vulpen M. Peters M, et al. Brachytherapy. 2016 Jan-Feb;15(1):85-93. doi: 10.1016/j.brachy.2015.10.004. Epub 2015 Nov 21. Brachytherapy. 2016. PMID: 26614233
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy.
Peters M, van der Voort van Zyp JR, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, Maenhout M, Kattevilder R, Verkooijen HM, van Rossum PS, Ahmed HU, Shah TT, Emberton M, van Vulpen M. Peters M, et al. Radiother Oncol. 2016 Apr;119(1):104-10. doi: 10.1016/j.radonc.2016.02.002. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897512 Free article.
Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer.
Peters M, van der Voort van Zyp JRN, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, Maenhout M, Kattevilder R, Verkooijen HM, van Rossum PSN, Ahmed HU, Shah TT, Emberton M, van Vulpen M. Peters M, et al. Among authors: van der voort van zyp jrn, van de pol s, van vulpen m, van rossum psn. Brachytherapy. 2016 May-Jun;15(3):296-305. doi: 10.1016/j.brachy.2016.01.004. Epub 2016 Mar 2. Brachytherapy. 2016. PMID: 26948662
92 results